# Xeinadin Topco 1 (Xeinadin Topco 1 Limited)

Private limited company registered in London, classed under “Activities of financial services holding companies”.

- Company number: 13833419
- Status: Active
- Type: Private limited company
- Incorporated: 7 January 2022
- Registered office: Level 5a, Maple House, 149 Tottenham Court Road, London, W1T 7NF
- Location: London
- Activity: Activities of financial services holding companies

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Xeinadin Topco 1 do?

Private limited company registered in London, classed under “Activities of financial services holding companies”.

### How much turnover does Xeinadin Topco 1 make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/xeinadin-topco-1-13833419

### Is Xeinadin Topco 1 profitable?

Xeinadin Topco 1's profit isn't public: small companies may file without a profit and loss account.

### Who runs and owns Xeinadin Topco 1?

Its directors are Peter James Anderson, Derry Crowley, Kevin Jeremy Dangerfield, John Dwyer, Thomas Michael Lightowler and 2 more. Its owners are shown to subscribers.

### Where is Xeinadin Topco 1 based?

Its registered office is Level 5a, Maple House, 149 Tottenham Court Road, London, W1T 7NF, in London.

### When was Xeinadin Topco 1 founded?

Xeinadin Topco 1 Limited was incorporated on 7 January 2022.

### Is Xeinadin Topco 1 still trading?

The register lists Xeinadin Topco 1 Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-04-24: Registered office address changed from 8th Floor Becket House, 36 Old Jewry London EC2R 8DD England to Level 5a, Maple House 149 Tottenham Court Road London W1T 7NF on 24 April …
- 2026-04-15: Appointment of Peter James Anderson as a director on 1 April 2026
- 2026-04-15: Termination of appointment of Neil Anthony Ballard as a director on 31 March 2026
- 2026-01-19: Statement of capital following an allotment of shares on 10 December 2025 · GBP 36,413.4973 (and 5 more like it since 23 July 2024)
- 2026-01-14: Cancellation of shares. Statement of capital on 9 December 2025 · GBP 36,363.6850 (and 15 more like it since 3 June 2024)
- 2026-01-09: Change of share class name or designation (and 24 more like it since 14 January 2024)
- 2026-01-08: Purchase of own shares (and 32 more like it since 15 May 2024)
- 2025-12-03: Group of companies' accounts made up to 31 May 2025
- 2025-11-06: Memorandum and Articles of Association (and 3 more like it since 21 May 2024)
- 2025-11-06: Resolutions (and 3 more like it since 17 May 2024)
- 2025-07-29: Consolidated accounts of parent company for subsidiary company period ending 31/05/24
- 2025-07-22: Appointment of Mr Kevin Jeremy Dangerfield as a director on 21 July 2025
- 2025-05-29: Termination of appointment of Chantelle Catharina Grobler as a director on 2 May 2025
- 2025-02-14: Group of companies' accounts made up to 31 May 2024
- 2024-03-07: Appointment of Chantelle Catharina Grobler as a director on 1 March 2024
- 2024-03-07: Termination of appointment of Simon Oliver Nice as a director on 21 February 2024

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/xeinadin-topco-1-13833419